Markets.com Logo

BEAM

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    16.1794$
  • Previous Close
    15.9183$
  • 52 Week Change
    21.73$
  • Day Range
    0.26$
  • 52 Week High/Low
    13.525$ - 35.25$
  • Dividend Per Share
    --
  • Market cap
    1 625 M$
  • EPS
    -1
  • Beta
    2.225
  • Volume
    --

About

The stock financial product symbol BEAM.US refers to Beam Therapeutics Inc., a biotechnology company focused on precision genetic medicines through base editing. The ".US" suffix generally indicates that the stock is listed on a United States stock exchange, specifically the Nasdaq. Beam Therapeutics aims to develop therapies for serious diseases by using a technology that enables precise and permanent changes to DNA bases, offering a potential alternative to traditional gene editing or gene therapy approaches.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

Stock Price of BEAM.US: Clinical Trial Results: Positive or negative data from clinical trials significantly impacts investor confidence and valuation.

Regulatory Approvals: FDA decisions on BEAM's therapies influence market access and revenue potential.

Market Sentiment: Overall investor optimism or pessimism towards biotechnology stocks affects BEAM's share price.

Competition: The presence of rival gene editing technologies impacts BEAM's market share and competitive advantage.

Financial Performance: BEAM's cash runway, research & development spending, and any potential revenue streams affect valuation.

Partnerships & Collaborations: Strategic alliances with larger pharmaceutical companies influence development progress and funding.

Broader Economic Conditions: Macroeconomic factors like interest rates and inflation impact overall investment decisions and risk appetite.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--